From trade wars to the threat of an actual kinetic war, seemingly nothing has managed to keep stocks down for long this year.

Is the Federal Reserve suddenly open to cutting U.S. interest rates as early as July? That’s what Wall Street investors want ...

Increasingly, the drumbeat of financial advisers who say $1 million won’t be enough for retirement is growing louder. On ...

Dear Quentin, When I leave my job would I be better off taking a $61,000 lump sum to roll over into an existing IRA or, ...

Melius analysts expect more AI-chip sales as demand grows for running AI models and for AMD’s new offerings to attract ...

U.S. inflation remained surprisingly muted through May, with limited impact from President Donald Trump’s tariffs. But U.S.

Trump Media, the parent of President Donald Trump’s social-media platform Truth Social, announced a $400 million ...

Sales of existing homes inched up slightly in May but remained depressed as buyers shied away from a housing market that ...

The cost of doing business for U.S. companies rose in June at the second-fastest pace in two and a half years, a pair of S&P ...

“I have no regrets about anything I did, or didn’t do, with my money. I spent it doing what I love to do: traveling as much ...

Amgen's weight-loss drug MariTide had a successful Phase 2 trial so the company is expanding development plans to study its use for heart disease and sleep apnea.

Oil prices fell toward their lowest levels of the session Monday, "despite the escalation in the Iran conflict as [U.S. airstrikes sought to cripple]( ...